Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kevin T. McDonagh
Lymphocyte Count Above 300 X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reply
Arthritis & Rheumatism
Related publications
Dendritic Cells Recovery After Umbilical Cord Blood Transplant Is Superior to Related Donor Transplant and Predicts Better Survival
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Successful Second Unrelated Donor Hematopoietic Stem Cell Transplant in a Patient With Dyskeratosis Congenital After First Graft Rejection
Experimental and Clinical Transplantation
Transplantation
Survival After T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-Hct) Using Post-Transplant Cyclophosphamide (PT-CY) Compared With HLA-Matched Related Donor (MRD) Transplant for Lymphomas
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology
HLA-DPA1 Mismatch Is Associated With Decreased Overall Survival Following Unrelated Donor Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Donor Derived T-Cell Large Granular Lymphocyte Leukemia After Cord Blood Transplant for Pediatric T-Cell Lymphoblastic Leukemia
Bone Marrow Transplantation
Transplantation
Hematology
Donor Risk Index Predicts Graft Failure Reliably but Not Post-Transplant Infections
Surgical Infections
Surgery
Infectious Diseases
Microbiology
Non-Transplant Patients With Haematologic Malignancies Have Better Survival Outcome Than Recipients of Haematopoietic Stem Cell Transplant (Hsct) After Admission to Intensive Care Unit (Icu)
Intensive Care Medicine Experimental
Critical Care
Intensive Care Medicine